GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

Home・Listă Acțiuni・BioArctic AB

B
BioArctic AB

Închisă

319.6 1.91

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

319

Maxim

320

Indicatori cheie
By Trading Economics
Venit	-208M -29M
Vânzări	-259M 133M
P/E Medie Sector	28.665 76.798
EPS	-0.98
Marjă de profit	-21.576
Angajați	122
EBITDA	-206M -18M

Statistici piață
By TradingEconomics
Capitalizare de piață	2.8B 29B
Deschiderea anterioară	317.69
Închiderea anterioară	319.6

BioArctic AB Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

19 dec. 2025, 17:29 UTC

Achiziții, Fuziuni, Preluări

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dec. 2025, 16:47 UTC

Principalele dinamici ale pieței

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dec. 2025, 16:10 UTC

Achiziții, Fuziuni, Preluări

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21 dec. 2025, 23:51 UTC

Market Talk

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21 dec. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 dec. 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

21 dec. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19 dec. 2025, 22:33 UTC

Câștiguri

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dec. 2025, 22:19 UTC

Câștiguri

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dec. 2025, 21:48 UTC

Achiziții, Fuziuni, Preluări

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec. 2025, 21:44 UTC

Câștiguri

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dec. 2025, 21:38 UTC

Câștiguri

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dec. 2025, 21:00 UTC

Market Talk

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dec. 2025, 20:23 UTC

Market Talk

Oil Futures End Down Week on Up Note -- Market Talk

19 dec. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dec. 2025, 18:38 UTC

Market Talk

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dec. 2025, 18:00 UTC

Market Talk

Câștiguri

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dec. 2025, 17:41 UTC

Câștiguri

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dec. 2025, 17:24 UTC

Market Talk

Câștiguri

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dec. 2025, 17:20 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

19 dec. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

19 dec. 2025, 16:29 UTC

Câștiguri

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dec. 2025, 16:20 UTC

Achiziții, Fuziuni, Preluări

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dec. 2025, 16:19 UTC

Achiziții, Fuziuni, Preluări

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dec. 2025, 16:18 UTC

Achiziții, Fuziuni, Preluări

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dec. 2025, 16:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 dec. 2025, 16:16 UTC

Market Talk

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dec. 2025, 16:05 UTC

Achiziții, Fuziuni, Preluări

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec. 2025, 16:04 UTC

Achiziții, Fuziuni, Preluări

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec. 2025, 15:37 UTC

Market Talk

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Comparație

Modificare preț

BioArctic AB Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.